117 related articles for article (PubMed ID: 27637901)
1. Chromosomal anomalies and prognostic markers for intracranial and spinal ependymomas.
Yang I; Nagasawa DT; Kim W; Spasic M; Trang A; Lu DC; Martin NA
J Clin Neurosci; 2012 Jun; 19(6):779-85. PubMed ID: 22516549
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups.
Hirose Y; Aldape K; Bollen A; James CD; Brat D; Lamborn K; Berger M; Feuerstein BG
Am J Pathol; 2001 Mar; 158(3):1137-43. PubMed ID: 11238062
[TBL] [Abstract][Full Text] [Related]
3. Implications of DNA Methylation Classification in Diagnosing Ependymoma.
Abe E; Suzuki M; Ichimura K; Arakawa A; Satomi K; Ogino I; Hara T; Iwamuro H; Ohara Y; Kondo A
World Neurosurg; 2024 May; 185():e1019-e1029. PubMed ID: 38479644
[TBL] [Abstract][Full Text] [Related]
4. MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.
Mohan D; Nambirajan A; Malik R; Sharma A; Suri V; Kaur K; Doddamani R; Garg A; Gupta S; Mallick S; Sharma MC
Hum Cell; 2024 May; 37(3):704-713. PubMed ID: 38411836
[TBL] [Abstract][Full Text] [Related]
5. Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages.
Zhang Q; Cheng S; Wang Y; Wang M; Lu Y; Wen Z; Ge Y; Ma Q; Chen Y; Zhang Y; Cao R; Li M; Liu W; Wang B; Wu Q; Jia W; Wang X
Nat Commun; 2021 Nov; 12(1):6867. PubMed ID: 34824203
[TBL] [Abstract][Full Text] [Related]
6. A systematic review of outcome in intramedullary ependymoma and astrocytoma.
Hamilton KR; Lee SS; Urquhart JC; Jonker BP
J Clin Neurosci; 2019 May; 63():168-175. PubMed ID: 30833131
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Spinal Ependymomas: An Epidemiologic Study.
Khalid SI; Kelly R; Adogwa O; Carlton A; Woodward J; Ahmed S; Khanna R; Bagley C; Cheng J; Shah S; Mehta AI
World Neurosurg; 2018 Jul; 115():e119-e128. PubMed ID: 29631082
[TBL] [Abstract][Full Text] [Related]
8. Adult Spinal Ependymomas: An Epidemiologic Study.
Khalid SI; Adogwa O; Kelly R; Metha A; Bagley C; Cheng J; O'Toole J
World Neurosurg; 2018 Mar; 111():e53-e61. PubMed ID: 29225135
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentation and outcomes for adult ependymoma patients.
Acquaye AA; Vera E; Gilbert MR; Armstrong TS
Cancer; 2017 Feb; 123(3):494-501. PubMed ID: 27679985
[TBL] [Abstract][Full Text] [Related]
10. MYCN amplification drives an aggressive form of spinal ependymoma.
Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
[TBL] [Abstract][Full Text] [Related]
11. Is NF2 a Key Player of the Differentially Expressed Gene Between Spinal Cord Ependymoma and Intracranial Ependymoma?
Kim KT; Lee CH; Chung CK; Kim JH
World Neurosurg; 2018 Oct; 118():e906-e917. PubMed ID: 30031196
[TBL] [Abstract][Full Text] [Related]
12. Pathological Classification of the Intramedullary Spinal Cord Tumors According to 2021 World Health Organization Classification of Central Nervous System Tumors, a Single-Institute Experience.
Park SH; Won JK; Kim CH; Phi JH; Kim SK; Choi SH; Chung CK
Neurospine; 2022 Sep; 19(3):780-791. PubMed ID: 36203303
[TBL] [Abstract][Full Text] [Related]
13. Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression.
San-Miguel T; Megías J; Monleón D; Navarro L; Muñoz-Hidalgo L; Montoliu C; Meri M; Roldán P; Cerdá-Nicolás M; López-Ginés C
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011000
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral-Induced Spinal Cord Gliomas in Rat Model.
Nagarajan PP; Tora MS; Neill SG; Federici T; Texakalidis P; Donsante A; Canoll P; Lei K; Boulis NM
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884748
[TBL] [Abstract][Full Text] [Related]
15. Methylation Profiling of Specific Genes in Ependymomas.
Kanit N; Yalcin P; Erbayraktar S; Ozer E
Turk Patoloji Derg; 2022; 38(3):213-218. PubMed ID: 34854470
[TBL] [Abstract][Full Text] [Related]
16. Grade III intradural extramedullary anaplastic ependymoma managed with near-complete resection and adjuvant radiotherapy: a case report.
Ando S; Tsuji O; Nagoshi N; Nori S; Suzuki S; Okada E; Yagi M; Irie R; Watanabe K; Nakamura M; Matsumoto M
Spinal Cord Ser Cases; 2021 Jan; 7(1):1. PubMed ID: 33468988
[TBL] [Abstract][Full Text] [Related]
17. Detecting the long non‑coding RNA signature related to spinal cord ependymal tumor subtype using a genome‑wide methylome analysis approach.
Wang L; Zhang C; Xie Y; Jiang W; Huang J; Guo S; Xu F; Wang J
Mol Med Rep; 2019 Aug; 20(2):1531-1540. PubMed ID: 31257484
[TBL] [Abstract][Full Text] [Related]
18. Resistance-promoting effects of ependymoma treatment revealed through genomic analysis of multiple recurrences in a single patient.
Miller CA; Dahiya S; Li T; Fulton RS; Smyth MD; Dunn GP; Rubin JB; Mardis ER
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29440180
[TBL] [Abstract][Full Text] [Related]
19. Genetic differences on intracranial versus spinal cord ependymal tumors: a meta-analysis of genetic researches.
Lee CH; Chung CK; Kim CH
Eur Spine J; 2016 Dec; 25(12):3942-3951. PubMed ID: 27637901
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
